Cargando…

Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype

BACKGROUND: Anemia is a common disorder in CKD patients. It is largely attributed to decreased erythropoietin (EPO) production and iron deficiency. Therefore, besides EPO, therapy includes iron replenishment. However, the latter induces oxidative stress. Haptoglobin (Hp) protein is the main line of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armaly, Zaher, El Qader, Amir Abd, Jabbour, Adel, Hassan, Kamal, Ramadan, Rawi, Bowirrat, Abdalla, Bisharat, Bishara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535251/ https://www.ncbi.nlm.nih.gov/pubmed/26268514 http://dx.doi.org/10.1186/s12882-015-0119-0

Ejemplares similares

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment
por: Armaly, Zaher, et al.
Publicado: (2012)

Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes
por: Bisharat, Bishara, et al.
Publicado: (2012)

Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients
por: Armaly, Zaher, et al.
Publicado: (2019)

Challenges faced by Arab women who are interested in becoming physicians
por: Bisharat, Bishara, et al.
Publicado: (2015)

Haptoglobin Phenotype Among Arab Patients With Mental Disorders
por: Armaly, Zaher, et al.
Publicado: (2018)

Acute kidney injury following isotretinoin treatment
por: Armaly, Zaher, et al.
Publicado: (2013)

Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO – Devic’s Disease): Clinic-Pathological Report and Review of the Literature
por: Adawi, Mohammad, et al.
Publicado: (2014)

Erdheim–Chester disease (ECD): Case report, clinical and basic investigations, and review of literature
por: Adawi, Mohammad, et al.
Publicado: (2016)

First Case Report of Smith–Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview
por: Nijim, Yousif, et al.
Publicado: (2016)

Maxillary and Frontal Bone Simultaneously Involved in Brown Tumor due to Secondary Hyperparathyroidism in a Hemodialysis Patient
por: Artul, Suheil, et al.
Publicado: (2013)

Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
por: Ganz, Tomas, et al.
Publicado: (2020)

Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches
por: Armaly, Zaher, et al.
Publicado: (2018)

Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: A Rare Case Report from Nephrology
por: Armaly, Zaher, et al.
Publicado: (2019)

Intravenous Iron Repletion Does Not Significantly Decrease Platelet Counts in CKD Patients with Iron Deficiency Anemia
por: Dossabhoy, Neville R., et al.
Publicado: (2013)

Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
por: Suzuki, Anna, et al.
Publicado: (2018)

Intravenous administration of iPS‐MSC(SPIONs) mobilized into CKD parenchyma and effectively preserved residual renal function in CKD rat
por: Sheu, Jiunn‐Jye, et al.
Publicado: (2020)

A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients With CKD
por: Greenwood, Sharlene A., et al.
Publicado: (2023)

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
por: Roger, Simon D., et al.
Publicado: (2017)

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients
por: Fukami, Kei, et al.
Publicado: (2014)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020)

Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
por: Hardy, S., et al.
Publicado: (2015)

Severe hypophosphataemia after intravenous iron administration
por: Anand, Gurpreet, et al.
Publicado: (2017)

Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage
por: Blackburn, Spiros L., et al.
Publicado: (2018)

Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study
por: AlSahow, Ali, et al.
Publicado: (2022)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Recurrent severe hypophosphatemia following intravenous iron administration
por: Nataatmadja, Melissa Stephanie, et al.
Publicado: (2020)

Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients
por: Koyama, Yu, et al.
Publicado: (2017)

Haptoglobin as a Biomarker
por: Naryzny, S. N., et al.
Publicado: (2021)

Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine
por: Nishimura, Masato, et al.
Publicado: (2015)

Distribution and diversity of the haemoglobin–haptoglobin iron-acquisition systems in pathogenic and non-pathogenic Neisseria
por: Harrison, Odile B., et al.
Publicado: (2013)

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
por: Macdougall, Iain C., et al.
Publicado: (2014)

Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo
por: Faria, Bernardo, et al.
Publicado: (2019)

Bleomycin-Induced Lung Injury After Intravenous Iron Administration
por: Saccone, Nicole, et al.
Publicado: (2022)

Molecular Modeling of the Human Hemoglobin-Haptoglobin Complex Sheds Light on the Protective Mechanisms of Haptoglobin
por: Nantasenamat, Chanin, et al.
Publicado: (2013)

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial‐IRON Trial
por: Núñez, Julio, et al.
Publicado: (2020)

Elevated Neutrophil Gelatinase Lipocalin Levels Are Associated With Increased Oxidative Stress in Hemodialysis Patients
por: Nevo, Adam, et al.
Publicado: (2018)

Regulation of mouse haptoglobin synthesis
Publicado: (1983)

Smoking, haptoglobin and fertility in humans
por: Bottini, N, et al.
Publicado: (2002)

Smoking, haptoglobin and fertility in humans
por: Bottini, N, et al.
Publicado: (2002)

Low Level of Haptoglobin in Lupus
por: Timlin, Homa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0seubdsb0dmaqcthbs8k8iiosd